[1]
S. G. Kwatra, “Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib”, Acta Derm Venereol, vol. 104, p. adv18452, May 2024.